| LD | Linear dichroism |
| AASLD | American Association for the Study of Liver Diseases |
| ALT | Alanine Aminotransferase |
| AMPK | AMP-activated Protein Kinase |
| APOC3 | Adipoprotein C3 |
| AST | Aspartate Aminotransferase |
| BMI | Body Mass Index |
| CB2 | Cannabinoid Receptor 2 |
| CK-18 | Cytokeratin 18 |
| CT | Computerized Tomography |
| CYP2E1 | Cytochrome P450 family 2 subfamily E member 1 |
| DGAT2 | Diacylglycerol O-Acyltransferase 2 |
| DHA | Docosahexaenoic Acid |
| DPP-4 | Incretin Mimetics and Dipeptidyl Peptidase-4 |
| EASL | European Association for the Study of the Liver |
| ELF | Enhanced Liver Fibrosis |
| FTO | Fat Mass and Obesity associated |
| FXR | Farnesoid X Receptor |
| GCKR | Glucokinase Regulatory Protein |
| GGT | γ-glutamyl Transferase |
| GLP1 | Glucagon-Like Peptide-1 |
| GRP-120 | G Protein-coupled Receptor 120 |
| GWAS | Genome-Wide Association Study |
| HDL | High-Density Lipoprotein |
| HPC | Hepatic Progenitor Cells |
| HSC | Hepatic Stellate Cells |
| IL-6 | Interleukin 6 |
| IR | Insulin Resistance |
| IRS-1 | Insulin Receptor Substrate-1 |
| IUGR | Intrauterine Growth Restriction |
| KC | Kupffer Cells |
| KLF-6 | Kruppel-Like Factor 6 |
| LDL | Low Density Lipoprotein |
| LFTs | Liver Function Tests |
| LPIN1 | Lipin 1 |
| LYPLAL1 | Lysophospholipase-Like 1 |
| MC4R | Melanocortin 4 Receptor |
| NAFLD | Non-Alcoholic Fatty Liver Disease |
| NASH | Non-Alcoholic Steatohepatitis |
| NCAN | Neurocan |
| NKT | Natural Killer T lymphocytes |
| PNFI | Pediatric NAFLD Fibrosis Index |
| PNPLA3 | Adiponutrin/Patatin-like Phospholipase Domain-containing 3 |
| PPARg | Peroxisome-Proliferator Activated Receptor-γ |
| PPP1R3B | Protein Phosphatase 1 Regulatory Subunit 3b |
| PYY | Peptide YY |
| ROS | Reactive Oxygen Species |
| SLD | Steatotic Liver Disease |
| SOD2 | Manganese-dependent Superoxide Dismutase |
| SREBP1c | Sterol Regulatory Binding Element |
| TNF-α | Tumor Necrosis Factor α |
| TONIC | Treatment of NAFLD in Children |